rs1799883, FABP2

N. diseases: 36
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. 12855223 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE However, the large majority of studies assessing the potential association between the Ala54Thr FABP2 variant and insulin resistance/type 2 diabetes did not account for the independent and substantial effects of body composition, habitual physical activity (PA) levels, and diet on insulin resistance. 12209017 2002
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE Our data suggested that Ala54Thr polymorphism of the FABP2 gene is not a major contributing factor for obesity and obesity with dyslipidemia in Japanese children. 11866034 2001
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE A missense mutation (A54T) in the fatty acid binding protein type 2 (FABP2) gene has been associated with insulin resistance and obesity. 11707533 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In conclusion, no major difference was associated with the beta3AR Trp64Arg or FABP2 Ala54Thr polymorphism in terms of type 2 diabetes or hyperlipidemia in young to older Japanese men. 11699048 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE (1) The Ala54 and Thr54 allele frequencies in Chinese were 0.71 and 0.29 respectively; (2) The FABP2-Ala54Thr variation was neither associated with fasting and post-challenged plasma glucose levels nor with NIDDM; (3) This variation was neither associated with fasting lipid profile nor with obesity; (4) The IGT subjects with genotype Thr54(+) (Thr54 homozygotes and heterozygotes) had lower fasting, 2-hour and total C-peptide levels and smaller AUC representing lesser C-peptide secretion after glucose challenge than those with genotype Thr54(-) (Ala54 homozygotes) (P = 0.04, 0.03, 0.01 and 0.01 respectively). 11593593 1999
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE (1) The Ala54 and Thr54 allele frequencies in Chinese were 0.71 and 0.29 respectively; (2) The FABP2-Ala54Thr variation was neither associated with fasting and post-challenged plasma glucose levels nor with NIDDM; (3) This variation was neither associated with fasting lipid profile nor with obesity; (4) The IGT subjects with genotype Thr54(+) (Thr54 homozygotes and heterozygotes) had lower fasting, 2-hour and total C-peptide levels and smaller AUC representing lesser C-peptide secretion after glucose challenge than those with genotype Thr54(-) (Ala54 homozygotes) (P = 0.04, 0.03, 0.01 and 0.01 respectively). 11593593 1999
Obesity
CUI: C0028754
Disease: Obesity
0.100 GeneticVariation BEFREE An alanine to threonine substitution at codon 54 of the fatty acid binding protein 2 (FABP2) gene has been associated with insulin resistance in Pima Indians and with obesity in aboriginal Canadians. 10337870 1999
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE The FABP2 Ala54Thr polymorphism was significantly associated with obesity (AT vs AA: OR = 2.633, 95%CI = 1.065-6.663, P = 0.036; TT vs AA: OR = 4.160, 95%CI = 1.609-10.757, P = 0.003) and metabolic syndrome (TT vs AA: OR = 2.273, 95%CI = 1.242-4.156, P = 0.008) by logistic regression with adjustment for covariates. 25730055 2015
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE The aim of this study was to investigate the association between FABP2 Ala54Thr genetic polymorphism and metabolic syndrome and some biochemical and anthropological parameters in elderly subjects. 22838187 2012
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE Metabolic syndrome and ALA54THR polymorphism of fatty acid-binding protein 2 in obese patients. 20723947 2011
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE AGT T174M, GNB3 825C>T, and APOC3 -455T>C genotypes were significantly associated with MetS (P = 0.018, 0.0056, and 0.029, respectively) for female adults, whereas FABP2 A54T genotype was associated with MetS (P = 0.040) for female adolescents. 15869758 2006
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE The odds ratio (adjusted for age and sex) for MS for the individuals carrying the Ala54Thr genotype was 1.240 (95% CI, 1.02-1.51; P = .03), whereas for those carrying the Thr54Thr genotype, it was 1.812 (95% CI, 1.28-2.57; P = .001). 16919542 2006
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE The Ala54Thr polymorphism in the fatty acid-binding protein 2 (FABP2) gene as well as the T-455C and C-482T polymorphisms in the apolipoprotein C-III (APOC3) gene promoter have been associated with features of the MS in specific populations. 15598690 2005
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE Our objectives were to determine whether Ala54Thr FABP2 and G-493T MTP polymorphisms are associated with increased risks of insulin resistance syndrome (IRS) in youth and/or modify the expression of accompanying dyslipidemia. 15547295 2005
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
0.080 GeneticVariation BEFREE The Ala54Thr polymorphism of the FABP2 gene is not associated with CHD, markers of the metabolic syndrome, or the fatty acid profile of serum lipids in Finnish CHD patients. 12189904 2002
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
0.050 GeneticVariation BEFREE The alanine to threonine amino acid substitution at codon 54 (Ala54Thr) of the intestinal fatty acid binding protein (FABP2) has been associated with elevated levels of insulin and blood glucose as well as with dyslipidemia. 26703680 2015
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
0.050 GeneticVariation BEFREE The results from the published studies on the association of fatty acid-binding protein 2 (FABP2) Ala54Thr polymorphism with dyslipidemia are conflicting and inconclusive. 20047744 2010
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
0.050 GeneticVariation BEFREE Our objectives were to determine whether Ala54Thr FABP2 and G-493T MTP polymorphisms are associated with increased risks of insulin resistance syndrome (IRS) in youth and/or modify the expression of accompanying dyslipidemia. 15547295 2005
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
0.050 GeneticVariation BEFREE Our data suggested that Ala54Thr polymorphism of the FABP2 gene is not a major contributing factor for obesity and obesity with dyslipidemia in Japanese children. 11866034 2001
Dyslipidemias
CUI: C0242339
Disease: Dyslipidemias
0.050 GeneticVariation BEFREE To investigate whether or not the intestinal fatty acid binding protein gene (FABP2)-Ala54Thr variation is related to non-insulin dependent diabetes mellitus (NIDDM), obesity, dyslipidemia and glucose stimulated insulin secretion (GSIS) in Chinese. 11593593 1999
Hypertriglyceridemia
CUI: C0020557
Disease: Hypertriglyceridemia
0.030 GeneticVariation BEFREE The Ala54Thr polymorphism of FABP2 was associated with high triglycerides levels, but not to GSD; suggesting that environmental factors modulate such susceptibility. 26019038 2016
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
0.030 GeneticVariation BEFREE Therefore, we aimed to test the hypotheses that in MDD-patients the FABP2 Ala54Thr-polymorphism would be (I) more prevalent than in sex- and age-matched controls, (II) associated with observed alterations in FA-metabolism, and (III) associated with CVD-risk factor waist circumference. 24340071 2013
Diabetes Mellitus
CUI: C0011849
Disease: Diabetes Mellitus
0.030 GeneticVariation BEFREE The Ala54Thr polymorphism of FABP2 gene increases affinity of intestinal fatty acid-binding protein 2 for long-chain dietary fatty acids (FA) in subjects without diabetes. 20484485 2010
Diabetes
CUI: C0011847
Disease: Diabetes
0.030 GeneticVariation BEFREE The Ala54Thr polymorphism of FABP2 gene increases affinity of intestinal fatty acid-binding protein 2 for long-chain dietary fatty acids (FA) in subjects without diabetes. 20484485 2010